Sort
15,842 grants matching “pancreatic cancer”
Elucidating the role of SHOC2 to enhance MEK inhibitor sensitivity in pancreatic cancer
$64,926Jason Kwon · Dana-Farber Cancer Inst · F32 · FY2020 · CA
Role of Obesity-Induced Immunosuppression in Pancreatic Cancer
$64,815Connie J Rogers · Pennsylvania State University, The · R03 · FY2013 · CA
Admin-Core-001
$64,809Channing J Der · Univ Of North Carolina Chapel Hill · P01 · FY2019 · CA
Defining RAS isoform- and mutation-specific roles in oncogenesis
$64,809Channing J Der · Univ Of North Carolina Chapel Hill · P01 · FY2019 · CA
Lineage specifiers governing pancreatic cancer growth and molecular subtype
$64,749Eric Lee Snyder · University Of Utah · R01 · FY2023 · CA
Lineage specifiers governing pancreatic cancer growth and molecular subtype
$64,748Eric Lee Snyder · University Of Utah · R01 · FY2022 · CA
Solid Tumor Therapeutics Research Program
$64,644Michael Barry Kastan · Duke University · P30 · FY2015 · CA
Invadopodia assembly in pancreatic tumor-associated fibroblasts
$64,614Silvia Mabel Goicoechea · University Of Toledo · R03 · FY2012 · CA
Modulating one-carbon metabolism with diet and targeted inhibitors to treat cancer
$64,554Matthew Joseph McBride · Princeton University · F32 · FY2020 · CA
Characterizing and Targeting the Hypoxic T Cell Surfaceome to Promote Immune Function in Cancer
$64,554James Robert Byrnes · University Of California, San Francisco · F32 · FY2020 · CA
CTGF in Pancreatic Tumor Growth
$64,244Amato J. Giaccia · Stanford University · R01 · FY2009 · CA
Precision Cancer Medicine and Investigational Therapeutics
$64,230Scott J Antonia · Duke University · P30 · FY2021 · CA
Project 3: Mechanism-Based Design ofCombination Therapies for Pancreatic Cancer
$64,017Tayyaba Hasan · Massachusetts General Hospital · P01 · FY2019 · CA
Rapid Autopsy Program
$63,919Surinder Kumar Batra · University Of Nebraska Medical Center · U54 · FY2015 · CA
The Role of glypican-1 in Pancreatic Cancer Development and Progression
$63,830Chery Angel Whipple · Dartmouth College · F32 · FY2013 · CA
Identification of MSKs as critical integrators of chromatin and transcription factor activation in melanoma
$63,746Douglas Barrows · Rockefeller University · F32 · FY2019 · CA
Proteomic and Genomic Characterizations of FOXP1 in Pancreatic Cancer
$63,746Brittany M Bowman · Univ Of North Carolina Chapel Hill · F32 · FY2019 · CA
Circulating tumor cells (CTCs) in EGFR-mutant human lung cancer
$63,666Christina L Costantino · Massachusetts General Hospital · F32 · FY2017 · CA
Gastrointestinal Cancer Program
$63,652Jennifer D Black · University Of Nebraska Medical Center · P30 · FY2024 · CA
Gastrointestinal Cancer Program
$63,650Jennifer D Black · University Of Nebraska Medical Center · P30 · FY2023 · CA
Gastrointestinal Cancer Program
$63,650Jennifer D Black · University Of Nebraska Medical Center · P30 · FY2022 · CA
EPIDERMAL GROWTH FACTOR AND PANCREATIC CANCER
$63,514University Of California Irvine · R01 · FY2000 · CA
Role of PALB2 in the DNA damage response and breast cancer suppression
$63,510Bing Xia · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2012 · CA
Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics
$63,494Phil Crews · University Of California Santa Cruz · R01 · FY2015 · CA
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
$63,490Gail E Sonenshein · Adecto Pharmaceuticals, Inc. · R41 · FY2016 · CA